A study by Pfizer and researchers at the University of Texas Medical Branch indicates the company’s COVID-19 vaccine is effective against mutations of the coronavirus.
Visit Business Insider’s homepage for more stories.
The COVID-19 vaccine from pharmaceutical companies Pfizer and BioNTech looks to be effective against 16 different mutations of the coronavirus, according to a study that has not yet undergone peer review.
Get the latest coronavirus business & economic impact analysis from Business Insider Intelligence on how COVID-19 is affecting industries.
Know the latest in healthcare industry with our Healthcare newsletter.